✦ LIBER ✦

Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia

✍ Scribed by Alan Lankford; Roberta Rogowski; Beal Essink; Elizabeth Ludington; H. Heith Durrence; Thomas Roth

Book ID: 116885175
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 227 KB
Volume: 13
Category: Article
ISSN: 1389-9457
DOI: 10.1016/j.sleep.2011.09.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of four doses of lum

Efficacy and safety of four doses of lumiracoxib versus diclofenac in patients with knee or hip primary osteoarthritis: A phase II, four-week, multicenter, randomized, double-blind, placebo-controlled trial

✍ Schnitzer, Thomas J. ;Beier, Jannie ;Geusens, Piet ;Hasler, Paul ;Patel, Sanjay 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 3 views

## Abstract ## Objective To compare the efficacy and tolerability of the novel cyclooxygenase 2‐selective inhibitor lumiracoxib with placebo and diclofenac in osteoarthritis (OA). ## Methods Adults (n = 583) with knee or hip OA were randomized to receive for 4 weeks lumiracoxib 50, 100, or 200 m

Effects of eszopiclone on safety, subjec

Effects of eszopiclone on safety, subjective measures of efficacy, and quality of life in elderly and nonelderly Japanese patients with chronic insomnia, both with and without comorbid psychiatric disorders: a 24-week, randomized, double-blind study

✍ Naohisa Uchimura, Atsushi Kamijo, Takao Takase 📂 Article 📅 2012 🏛 BioMed Central 🌐 English ⚖ 436 KB

Efficacy and safety of doxepin 6&#xa0;mg in a four-week outpatient trial of elderly adults with chronic primary insomnia

Efficacy and safety of doxepin 6 mg in a four-week outpatient trial of elderly adults with chronic primary insomnia